Double Helix Market Access and Consulting
Double Helix Consulting is an established strategic market access consultancy based in London, New York and Singapore.
Founded in 1995 by Wayne Phillips, Double Helix is a privately owned, well established and rapidly growing pharmaceutical market access consultancy dedicated to the Life Sciences sector, providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses. Wayne is a physician with over 30 years' experience in the pharmaceutical industry, of which 16 years was in clinical development and medical marketing. After spending several years working for the pharmaceutical industry where he gained expertise in clinical development, biostatistics, regulatory affairs and medical communications, Wayne's background enabled him to found Double Helix with a vision to create a global healthcare consultancy
As experienced practitioners of innovative, robust and actionable solutions in tactical and strategic market research, market access, pricing and reimbursement, HEOR and Medical Devices, Biotechnologies & Diagnostics, Double Helix's services are global in reach - spanning all key markets worldwide, as well as covering local UK and US domestic market needs.
Alerts
Stakeholder Engagement & Communication
Pharmacists and Nurses are viable touch points within the patient care pathway with untapped potential. Click here to find out why partnership would support your brand's commercial strategy.
Headlines
DHC Webinar on China's Drug Policy Reform took place on 20th April, 2012
If you wish to download a PDF copy of the slides please click here.
Next China themed Educational event will be a symposium at ISPOR Washington this June
Perspectives for the med tech and diagnostics sector from the US managed markets, EU and China will be presented during a debate on trends in evidence expectations across these markets.